A detailed history of Union Bancaire Privee, Ubp Sa transactions in Moderna, Inc. stock. As of the latest transaction made, Union Bancaire Privee, Ubp Sa holds 22,015 shares of MRNA stock, worth $599,248. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,015
Previous 38,004 42.07%
Holding current value
$599,248
Previous $1.58 Million 60.51%
% of portfolio
0.01%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 16, 2025

SELL
$28.35 - $47.53 $453,288 - $759,957
-15,989 Reduced 42.07%
22,015 $624,000
Q4 2024

Jan 22, 2025

BUY
$36.85 - $63.93 $1.4 Million - $2.43 Million
38,004 New
38,004 $1.58 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $10.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Union Bancaire Privee, Ubp Sa Portfolio

Follow Union Bancaire Privee, Ubp Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Union Bancaire Privee, Ubp Sa, based on Form 13F filings with the SEC.

News

Stay updated on Union Bancaire Privee, Ubp Sa with notifications on news.